| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 3.751 | 44.756 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 3.801 | 44.756 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 12.412 | 42.708 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -8.611 | 2.048 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -8.649 | 1.515 |
| Employees | - | - | - | - | - | - | - | - | 1 | 1 |
Check the financial reports for the company - Amefsib S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 528 | 432 |
| Current Assets | - | - | - | - | - | - | - | - | 2.082 | 13.200 |
| Inventories | - | - | - | - | - | - | - | - | 1.342 | 4.916 |
| Receivables | - | - | - | - | - | - | - | - | 36 | 736 |
| Cash | - | - | - | - | - | - | - | - | 705 | 7.548 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -8.609 | -7.059 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 11.219 | 20.691 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9510 - 9510" | |||||||||
| CAEN Financial Year |
9511
|
|||||||||
Comments - Amefsib S.r.l.